NS COVID-19 The WHO has said that numbers in the Southeast Asia region peaked in early May and have stabilized substantially over the past month, mainly with cases stabilizing in India and in Indonesia and Myanmar over the past month. Due to the continuous decrease.
The COVID-19 weekly epidemiological update issued by the World Health Organization on August 10 said that the South-East Asia region has reported more than 799,000 new cases, a five percent decrease from the previous week, however, in many countries. The region continues to report an increasing trend, including Sri Lanka and Thailand (growth of 26 percent and 20 percent, respectively).
Case incidence in the region peaked in early May and has since stabilized substantially over the past month. This is largely due to the steady state of cases in India and a steady decline in Indonesia and Myanmar over the past month, the update said.
This is the first time in seven weeks that there has been a decline in the number of new weekly deaths, following a sharp increase in the death rate in the region, it said; A trend driven by declines in the Maldives and Myanmar this week.
Large increases in weekly deaths were reported in several countries, including Sri Lanka (an increase of 47 percent), Nepal (35 percent) and Thailand (30 percent).
The highest number of new cases were reported from India (278,631 new cases; 20.2 new cases per 100,000; a decrease of 2 percent), Indonesia (225,635 new cases; 82.5 new cases per 100,000; a decrease of 18 percent), and Thailand (141,191 new cases). cases) cases; 202.3 new cases per 100,000; 20% increase).
In the region, the highest number of new deaths were reported from Indonesia (11,373 new deaths; 4.2 new deaths per 100,000; 9 per cent decrease), India (3511 new deaths; 0.3 new deaths per 100,000; 8 per cent decrease), and Myanmar (2045 new deaths; 3.8 new deaths per 100,000; 22 percent decrease).
Globally, cases of the alpha variant have been reported in 185 countries, regions or territories, while 142 countries have reported cases. delta version, 136 countries reported cases for the beta version and 81 countries reported cases for the gamma version.
The update said the cumulative number of COVID-19 cases globally on August 5 exceeded 200 million, six months after reaching 100 million cases.
This week alone, more than 4.2 million new cases and more than 65,000 new deaths were recorded, a slight increase from the previous week.
The largest proportionate increase in new cases was recorded by the Americas region (14 percent) and the Western Pacific region (19 percent), with over 1.3 million and 375 000 new cases, respectively.
Of the 228 member states and territories, 38 (17 percent) reported a higher TEMP than a 50 percent increase in new cases compared to the previous week and 34 (15 percent) reported a 50 percent increase in new deaths. reported more TEMP in.
At the country level, the United States reported the highest number of new cases at 734,354, an increase of 35 percent, with India reporting 278,631 new cases; A decrease of two percent), Iran (248,102 new cases; an increase of 20 percent), Brazil (228,473 new cases; a decrease of 8 percent), and Indonesia (225,635 new cases; a decrease of 18 percent).
The update states that eight recent studies have assessed the impact of the delta variant on COVID-19 vaccine performance.
It cited a study from India, which has not yet been peer-reviewed and that assessed the effectiveness of the AstraZeneca-Vaxegaveria vaccine for preventing SARS-CoV-2 infection and severe COVID-19 disease. .
The India study found that two doses of the AstraZeneca-Vaxegaveria vaccine were 63.1 percent and 81.5 percent effective in preventing infection and moderate-severe disease, respectively.
Single-dose VE against infection (46.2 percent) had a lower TEMP than two-dose VE, while single-dose VE against moderate-severe disease (79.2 percent) was similar to date of 2 doses.
It said that this study was conducted during a time of high transmission of the delta variant, noting that viral sequencing and lineage determination were available from only a small subset of positive cases (4.4%); 90% of these samples were delta variants.
A report on the first local transmission of the delta SARS-CoV-2 variant in China described the viral infection and traced the transmission dynamics of 167 cases back to the index case.
Daily sequential PCR testing of the quarantined subjects indicated that in those who had become infected, the viral load of the first positive test of Delta infection was approximately 1000 times higher than the TEMP of the original non-variant of concern strain, which was rapidly virulent. suggests the possibility. Replication of the delta variant and increased infectivity during the early stages of infection.
.